Women's Health
Adolescents estimate gestational duration as accurately as older counterparts
Adolescents seeking an abortion demonstrated comparable accuracy in estimating gestational duration as older age groups, according to a research letter published in JAMA Pediatrics.
Surgical approach largest predictor of cost with outpatient hysterectomy in US
In the U.S., surgical approach was the single strongest predictor of total costs for an outpatient hysterectomy for benign indications, according to study results published in Obstetrics & Gynecology.
Black women experience high likelihood of urine toxicology testing at delivery
Black women had a greater probability of undergoing urine toxicology testing at delivery compared with other racial groups regardless of substance use history, researchers reported in JAMA Health Forum.
Small increase in likelihood of greater bleeding during menses after COVID-19 vaccination
Women reported a small increase in the likelihood of greater total bleeding during a menstrual cycle after receiving the COVID-19 vaccine, according to an observational study published in BJOG.
Greater dietary antioxidant intake linked to decreased osteoporosis risk in menopause
Among postmenopausal women, consuming more dietary antioxidants was associated with decreased likelihood of osteoporosis, according to a population-based study published in Menopause.
Worse pregnancy outcomes with COVID-19 at delivery
Pregnant women with COVID-19 infection at delivery in the U.S. experienced substantial adverse outcomes early during the pandemic, researchers reported in JAMA Network Open.
Q&A: Impact of endocrine-disrupting chemicals on reproduction, pregnancy
Endocrine-disrupting chemicals have clear adverse effects on reproduction, pregnancy and fetal development in animal models. Despite difficulties in studying these chemicals in humans, experts warn that their effects are serious.
Prenatal telehealth visits increase early in COVID-19 pandemic
Early in the COVID-19 pandemic, prenatal telehealth visits increased substantially with higher telehealth rates particularly among patients with Medicaid, according to a cross-sectional study published in JAMA Network Open.
Polycystic ovary syndrome not associated with hidradenitis suppurativa severity
NEW ORLEANS — While prevalent among women with hidradenitis suppurativa, polycystic ovary syndrome is not associated with increased hidradenitis suppurativa disease severity, according to a poster presented here.
FDA requires withdrawal of preterm birth prevention drug approval
The FDA withdrew approval of hydroxyprogesterone caproate injection, the only drug that had been approved to reduce risk for preterm birth in women with a history of spontaneous preterm birth, according to an agency press release.